Old Web
English
Sign In
Acemap
>
authorDetail
>
Luke B. Fletcher
Luke B. Fletcher
University of Southern California
Chronic lymphocytic leukemia
Viability assay
Syk
Cancer research
Kinase
2
Papers
40
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients
2017
PLOS ONE
Luke B. Fletcher
Rianne Veenstra
Eric Y. Loo
Amie E. Hwang
Imran N. Siddiqi
Lydia Visser
Bouke G. Hepkema
Ilja M. Nolte
Anke van den Berg
Wendy Cozen
Arjan Diepstra
Show All
Source
Cite
Save
Citations (5)
The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia
2013
Journal of Pharmacology and Experimental Therapeutics
Stephen E. Spurgeon
Greg Coffey
Luke B. Fletcher
Russell T. Burke
Jeffrey W. Tyner
Brian J. Druker
Andreas Betz
Francis DeGuzman
Yvonne Pak
Dale A. Baker
Anjali Pandey
Stanley J. Hollenbach
Uma Sinha
Marc Loriaux
Show All
Source
Cite
Save
Citations (35)
1